These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 32154920)

  • 1. Familial risk of breast cancer by dynamic, accumulative, and static definitions of family history.
    Mukama T; Kharazmi E; Sundquist K; Sundquist J; Brenner H; Fallah M
    Cancer; 2020 Jun; 126(12):2837-2848. PubMed ID: 32154920
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Risk-adapted starting age of breast cancer screening in women with a family history of ovarian or other cancers: A nationwide cohort study.
    Mukama T; Kharazmi E; Sundquist K; Sundquist J; Fallah M
    Cancer; 2021 Jun; 127(12):2091-2098. PubMed ID: 33620751
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A comprehensive evaluation of family history and breast cancer risk. The Utah Population Database.
    Slattery ML; Kerber RA
    JAMA; 1993 Oct; 270(13):1563-8. PubMed ID: 8371466
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Age-specific breast cancer risk by body mass index and familial risk: prospective family study cohort (ProF-SC).
    Hopper JL; Dite GS; MacInnis RJ; Liao Y; Zeinomar N; Knight JA; Southey MC; Milne RL; Chung WK; Giles GG; Genkinger JM; McLachlan SA; Friedlander ML; Antoniou AC; Weideman PC; Glendon G; Nesci S; ; Andrulis IL; Buys SS; Daly MB; John EM; Phillips KA; Terry MB
    Breast Cancer Res; 2018 Nov; 20(1):132. PubMed ID: 30390716
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Risk of invasive breast cancer in relatives of patients with breast carcinoma in situ: a prospective cohort study.
    Mukama T; Fallah M; Brenner H; Xu X; Sundquist K; Sundquist J; Kharazmi E
    BMC Med; 2020 Nov; 18(1):295. PubMed ID: 33148280
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prophylactic Oophorectomy: Reducing the U.S. Death Rate from Epithelial Ovarian Cancer. A Continuing Debate.
    Piver MS
    Oncologist; 1996; 1(5):326-330. PubMed ID: 10388011
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Family history and risk of breast cancer: an analysis accounting for family structure.
    Brewer HR; Jones ME; Schoemaker MJ; Ashworth A; Swerdlow AJ
    Breast Cancer Res Treat; 2017 Aug; 165(1):193-200. PubMed ID: 28578505
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The impact of in situ breast cancer and family history on risk of subsequent breast cancer events and mortality - a population-based study from Sweden.
    Sackey H; Hui M; Czene K; Verkooijen H; Edgren G; Frisell J; Hartman M
    Breast Cancer Res; 2016 Oct; 18(1):105. PubMed ID: 27756431
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Risk of Second Cancer in Hodgkin Lymphoma Survivors and Influence of Family History.
    Sud A; Thomsen H; Sundquist K; Houlston RS; Hemminki K
    J Clin Oncol; 2017 May; 35(14):1584-1590. PubMed ID: 28384078
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Regular use of aspirin and other non-steroidal anti-inflammatory drugs and breast cancer risk for women at familial or genetic risk: a cohort study.
    Kehm RD; Hopper JL; John EM; Phillips KA; MacInnis RJ; Dite GS; Milne RL; Liao Y; Zeinomar N; Knight JA; Southey MC; Vahdat L; Kornhauser N; Cigler T; Chung WK; Giles GG; McLachlan SA; Friedlander ML; Weideman PC; Glendon G; Nesci S; ; Andrulis IL; Buys SS; Daly MB; Terry MB
    Breast Cancer Res; 2019 Apr; 21(1):52. PubMed ID: 30999962
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Family history of breast cancer as a second primary malignancy in relatives: a nationwide cohort study.
    Zheng G; Sundquist J; Sundquist K; Ji J
    BMC Cancer; 2021 Nov; 21(1):1210. PubMed ID: 34772394
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Familial breast cancer: collaborative reanalysis of individual data from 52 epidemiological studies including 58,209 women with breast cancer and 101,986 women without the disease.
    Collaborative Group on Hormonal Factors in Breast Cancer
    Lancet; 2001 Oct; 358(9291):1389-99. PubMed ID: 11705483
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Risk-Adapted Starting Age of Screening for Relatives of Patients With Breast Cancer.
    Mukama T; Kharazmi E; Xu X; Sundquist K; Sundquist J; Brenner H; Fallah M
    JAMA Oncol; 2020 Jan; 6(1):68-74. PubMed ID: 31725845
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Risks of Breast, Ovarian, and Contralateral Breast Cancer for BRCA1 and BRCA2 Mutation Carriers.
    Kuchenbaecker KB; Hopper JL; Barnes DR; Phillips KA; Mooij TM; Roos-Blom MJ; Jervis S; van Leeuwen FE; Milne RL; Andrieu N; Goldgar DE; Terry MB; Rookus MA; Easton DF; Antoniou AC; ; McGuffog L; Evans DG; Barrowdale D; Frost D; Adlard J; Ong KR; Izatt L; Tischkowitz M; Eeles R; Davidson R; Hodgson S; Ellis S; Nogues C; Lasset C; Stoppa-Lyonnet D; Fricker JP; Faivre L; Berthet P; Hooning MJ; van der Kolk LE; Kets CM; Adank MA; John EM; Chung WK; Andrulis IL; Southey M; Daly MB; Buys SS; Osorio A; Engel C; Kast K; Schmutzler RK; Caldes T; Jakubowska A; Simard J; Friedlander ML; McLachlan SA; Machackova E; Foretova L; Tan YY; Singer CF; Olah E; Gerdes AM; Arver B; Olsson H
    JAMA; 2017 Jun; 317(23):2402-2416. PubMed ID: 28632866
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Family History and Breast Cancer Risk Among Older Women in the Breast Cancer Surveillance Consortium Cohort.
    Braithwaite D; Miglioretti DL; Zhu W; Demb J; Trentham-Dietz A; Sprague B; Tice JA; Onega T; Henderson LM; Buist DSM; Ziv E; Walter LC; Kerlikowske K;
    JAMA Intern Med; 2018 Apr; 178(4):494-501. PubMed ID: 29435563
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A cohort study of reproductive factors and family history of breast cancer in southern Sweden.
    Olsson H; Bladström A
    Breast Cancer Res Treat; 2002 Dec; 76(3):203-9. PubMed ID: 12462381
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Timing of familial breast cancer in sisters.
    Rebora P; Czene K; Reilly M
    J Natl Cancer Inst; 2008 May; 100(10):721-7. PubMed ID: 18477799
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 10-year performance of four models of breast cancer risk: a validation study.
    Terry MB; Liao Y; Whittemore AS; Leoce N; Buchsbaum R; Zeinomar N; Dite GS; Chung WK; Knight JA; Southey MC; Milne RL; Goldgar D; Giles GG; McLachlan SA; Friedlander ML; Weideman PC; Glendon G; Nesci S; Andrulis IL; John EM; Phillips KA; Daly MB; Buys SS; Hopper JL; MacInnis RJ
    Lancet Oncol; 2019 Apr; 20(4):504-517. PubMed ID: 30799262
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The genetic epidemiology of second primary breast cancer.
    Bernstein JL; Thompson WD; Risch N; Holford TR
    Am J Epidemiol; 1992 Oct; 136(8):937-48. PubMed ID: 1456270
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Familial risks of breast and prostate cancers: does the definition of the at risk period matter?
    Brandt A; Bermejo JL; Sundquist J; Hemminki K
    Eur J Cancer; 2010 Mar; 46(4):752-7. PubMed ID: 20022238
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.